Publication: Optimal Long-Acting Injectable Antipsychotic Management During COVID-19
No Thumbnail Available
Date
2021-01-12
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Physicians Postgraduate Press, Inc
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
MacLaurin, Sarah A., Caitlin Mulligan, Manjola Ujkaj Van Alphen, Oliver Freudenreich. "Optimal Long-Acting Injectable Antipsychotic Management During COVID-19." J. Clin. Psychiatry 82, no. 1 (2021). DOI: 10.4088/jcp.20l13730
Research Data
Abstract
N/A (letter)
Description
Letter describes our clinics experience with provision of long-acting injectable antipsychotics during the COVID-19 pandemic.
Other Available Sources
Keywords
Psychiatry and Mental health
Terms of Use
Metadata Only